Vetoquinol SA (VETO.PA) stock: key figures, P/E, revenue and dividend
Health Care · France · ISIN FR0004186856
Vetoquinol SA financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 539.00 m EUR | 525.00 m EUR |
| Gross profit | 387.00 m EUR | 160.00 m EUR |
| EBIT | 77.00 m EUR | 73.00 m EUR |
| Net income | 58.00 m EUR | 57.00 m EUR |
| Diluted EPS – continuing operations | 4.97 EUR | 4.79 EUR |
Full history since 2003, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Vetoquinol SA
Vetoquinol SA, a veterinary pharmaceutical company, engages in designing, developing, and selling of veterinary drugs and non-medicinal products for cattle, pigs, dogs, and cats in Europe, the Americas, and the Asia Pacific region. It offers products in the areas of mobility, pain, and inflammation; dermatology, hygiene, and care; anti-parasite; udder health; antibiotics; reproduction; behavior management; internal medicine; and cardio-nephrology. The company was founded in 1933 and is headquartered in Lure, France. Vetoquinol SA operates as a subsidiary of Soparfin SCA.
More stocks
- Alphatec Holdings, Inc. (ATEC)
- FIRSTSUN CAPITAL BANCORP (FSUN)
- Norbit ASA (NORBT.OL)
- Hannstar Display Corp (6116.TW)
- Instalco AB (INSTAL.ST)
- Xinjiang Lixin Energy Co. Ltd. A (001258.SZ)
- CHANNEL VAS INV LTD (OPA.JO)
- Wangneng Environment Co Ltd (002034.SZ)
- Guangdong Xianglu Tungsten Co Ltd (002842.SZ)
- Brighton-Best International Taiwan (8415.TWO)
- 74Software SA (74SW.PA)
- CITIC Telecom International Holdings Ltd (1883.HK)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.